Objectives To assess the associations of severe non‐adherence to HCQ, objectively
assessed by HCQ serum levels, and risks of SLE flares, damage, and mortality over 5 years …

Objective Hydroxychloroquine (HCQ) is widely used in patients with systemic lupus
erythematosus (SLE), but its effects on the mortality have not reached a definite conclusion …

Objective The goals of this study were to assess the associations of severe nonadherence to
hydroxychloroquine (HCQ), objectively assessed by HCQ serum levels, and risks of …

The incidence and mortality of cancer are increasing, making it a leading cause of death
worldwide. Conventional treatments such as surgery, radiotherapy, and chemotherapy face …

Objective Regional variations in systemic lupus erythematosus (SLE) mortality may be due
to different spectra of local environmental factors. The aim of this study was to assess …

Objectives Infection is a leading cause of death in patients with systemic lupus
erythematosus (SLE). Alt hough hydroxychloroquine (HCQ) has been reported to inhibit …

Résumé L'intelligence artificielle (IA) utilisant le deep learning est en train de révolutionner
plusieurs domaines, y compris la médecine, avec des applications très variées. Disponible …

To explore the etiology of risk factors and quantify the mortality differences in systemic lupus
erythematosus (SLE) patients with different initial disease activity. The Jiangsu Lupus …

Objectives To test the association of use of antimalarials with the overall safety of treatment
in RA patients receiving one or multiple courses of biologic (b) DMARDs or a Janus kinase …

Cognitive impairment is frequently reported among anti-phospholipid syndrome (APS)
patients as well as anti-phospholipid antibody (aPL) carriers, but it is less studied than other …